# Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

> **NCT05417971** · — · RECRUITING · sponsor: **Northside Hospital, Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Hematologic Malignancy

## Interventions

- **OTHER:** Fludarabine

## Key facts

- **NCT ID:** NCT05417971
- **Lead sponsor:** Northside Hospital, Inc.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-29
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05417971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05417971, "Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05417971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*